Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The nature of post-treatment support and discharge arrangements for patientsundergoing intensive care support due to their COVID+ status is likely to be different tocurrent pathways out of general medical beds. NHSE&I&I needs support to enable it to plan for people discharged from hospitalrecovering from COVID19, to ensure that scarce ICU beds and other acute beds areused for the most appropriate patients.The outputs can be used both for non-clinical planning purpose but also inform clinicalguidelines on the appropriate step down processes from ICU
Additional information:
The nature of post-treatment support and discharge arrangements for patients undergoing intensive care support due to their COVID+ status is likely to be different to current pathways out of general medical beds. NHSE&I&I needs support to enable it to plan for people discharged from hospital recovering from COVID19, to ensure that scarce ICU beds and other acute beds are used for the most appropriate patients. The outputs can be used both for non-clinical planning purpose but also inform clinical guidelines on the appropriate step down processes from ICU
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| NEWTON EUROPE LIMITED | - | £115,650 | - |